Displaying 106 - 110 of 180
Mon 09 February 2015
The Scottish Medicines Consortium have approved the use of Abraxane in Scotland.Read More about 'SMC approve Abraxane in Scotland'
Tue 03 February 2015
Research, led by Drs John Timms and Steve Pereira at UCL, shows that tumour markers could be used to aid early detection of pancreatic cancer.Read More about 'Tumour biomarkers research shows promise for early detection'
Fri 16 January 2015
The day, which sees people raise awareness and funds for Pancreatic Cancer UK, was inspired by a character that actor Roger Lloyd-Pack famously played. When Roger sadly died of pancreatic cancer in January 2014, Pancreatic Cancer UK supporter, Tom Kenning created this tribute to him.Read More about 'Call Everyone Dave Day is back!'
Mon 12 January 2015
National charity Pancreatic Cancer UK says patients feel relieved that Abraxane® – hailed as the first breakthrough drug for pancreatic cancer in 20 years - will not be immediately removed from the Cancer Drugs Fund (CDF) List.Read More about ''Cautiously optimistic': Abraxane will not be removed from the CDF'
Tue 30 December 2014
NICE has today confirmed that it has not recommended Abraxane for use by the NHS in England for patients with metastatic pancreatic cancer, on cost grounds. This decision will also affect patients in Northern Ireland.Read More about 'NICE says NO to Abraxane for advanced pancreatic cancer'